DMK Pharmaceuticals Corporation (DMKPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 30, 2024, 4:00 PM EDT
DMK Pharmaceuticals Revenue
DMK Pharmaceuticals had revenue of $9.06K in the quarter ending September 30, 2023, a decrease of -99.40%. This brings the company's revenue in the last twelve months to $3.62M, up 150.33% year-over-year. In the year 2022, DMK Pharmaceuticals had annual revenue of $4.76M with 115.34% growth.
Revenue (ttm)
3.62M
Revenue Growth
+150.33%
P/S Ratio
n/a
Revenue / Employee
301.64K
Employees
12
Market Cap
10.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 4.76M | 2.55M | 115.34% |
Dec 31, 2021 | 2.21M | -567.91K | -20.45% |
Dec 31, 2020 | 2.78M | -19.34M | -87.44% |
Dec 31, 2019 | 22.11M | 7.03M | 46.58% |
Dec 31, 2018 | 15.09M | 2.01M | 15.40% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Mar 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |